Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:15 am Sale | 2023-12-31 | 13G | Valvoline Inc. VVV | VIKING GLOBAL INVESTORS LP | 3,176,309 2.400% | -5,162,147 (-61.91%) | Filing History |
| 2024-02-14 10:13 am Sale | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% | -713,420 (-12.18%) | Filing History |
| 2024-02-14 10:12 am Purchase | 2023-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS | VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% | 1,500,000 (+22.99%) | Filing History |
| 2024-02-14 10:11 am Sale | 2023-12-31 | 13G | Five9, Inc. FIVN | VIKING GLOBAL INVESTORS LP | 2,714,117 3.700% | -933,478 (-25.59%) | Filing History |
| 2024-02-14 10:00 am Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | VIKING GLOBAL INVESTORS LP | 2,531,829 9.990% | 1,211,173 (+91.71%) | Filing History |
| 2024-02-14 10:00 am Purchase | 2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | VIKING GLOBAL INVESTORS LP | 7,150,826 15.100% | 511,627 (+7.71%) | Filing History |
| 2024-02-05 4:29 pm Unchanged | 2024-02-01 | 13D | Cazoo Group Ltd CZOOF | VIKING GLOBAL INVESTORS LP | 21,427 43.800% | 0 (Unchanged) | Filing History |
| 2024-01-30 4:31 pm Purchase | 2024-01-20 | 13G | ORIC Pharmaceuticals, Inc. ORIC | VIKING GLOBAL INVESTORS LP | 4,000,000 5.900% | 4,000,000 (New Position) | Filing History |
| 2024-01-09 4:46 pm Purchase | 2024-01-05 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% | 20,817,249 (+251.14%) | Filing History |
| 2024-01-08 4:15 pm Sale | 2024-01-04 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 4,247,914 9.900% | -540,000 (-11.28%) | Filing History |
| 2024-01-08 4:05 pm Purchase | 2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 4,787,914 11.200% | 850,000 (+21.59%) | Filing History |
| 2023-12-08 4:10 pm Purchase | 2023-12-06 | 13D | Cazoo Group Ltd CZOOF | VIKING GLOBAL INVESTORS LP | 21,427 43.800% | 21,427 (New Position) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | 0 (Unchanged) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% | 0 (Unchanged) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-11-03 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-11-07 4:10 pm Unchanged | 2023-11-03 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-11-02 4:30 pm Purchase | 2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% | 5,858,532 (New Position) | Filing History |
| 2023-10-16 4:30 pm Sale | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | -34,705 (-0.42%) | Filing History |
| 2023-10-06 4:15 pm Purchase | 2023-09-26 | 13G | Five9, Inc. FIVN | VIKING GLOBAL INVESTORS LP | 3,647,595 5.100% | 3,647,595 (New Position) | Filing History |
| 2023-09-22 5:24 pm Unchanged | 2023-09-20 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |